Your browser is not supported.

To view this content, please use one of the following browsers:

  • Microsoft Edge
  • Chrome
  • Safari

By continuing to view this video or podcast, you confirm that you are a healthcare professional. Mundipharma owns all rights, including copyrights, to this recording. The recording (or any link to it) may not be changed, supplemented or redistributed without the express written consent of Mundipharma.

High risk populations: Invasive fungal infections in patients with haematological malignancies

Markus Ruhnke and Johan Maertens and discuss the burden of the most common types of invasive fungal infections in patients with haematological malignancies, how they are diagnosed and long-term outcomes for these patients

SciA-AFN-2400015 | February 2024